Why Is My Eye Pressure High With Anterior Uveitis?
At a Glance
High eye pressure in anterior uveitis can be caused by inflammatory debris (uveitic glaucoma) or as a side effect of steroid eye drops (steroid-induced glaucoma). Because pressure spikes often have no symptoms, regular eye exams are essential to detect and treat them early.
Yes, steroid eye drops can cause your eye pressure to rise, which in turn can lead to a condition called steroid-induced glaucoma. However, it is important to know that high eye pressure can also be caused by the anterior uveitis itself (known as uveitic glaucoma). While both conditions result in elevated eye pressure, they happen for entirely different reasons.
Important Safety Warning: Never stop or reduce your prescribed steroid eye drops without your doctor’s guidance. Because uncontrolled inflammation can also cause severe pressure spikes and permanent vision damage, abruptly stopping your medication to “protect” yourself from steroids can be dangerous.
Understanding how your eye’s drainage system works is the key to understanding both conditions. Your eye constantly produces fluid (aqueous humor) that nourishes the front of the eye. This fluid drains out through a spongy tissue called the trabecular meshwork. When this drain gets blocked or stops working properly, fluid builds up, raising the pressure inside your eye. If the pressure stays high for too long, it can damage the optic nerve, which is the hallmark of glaucoma. High eye pressure often has absolutely no symptoms in its early to moderate stages. You likely will not “feel” the pressure going up, which makes keeping your scheduled appointments crucial.
Steroid-Induced Glaucoma
For some people—often referred to as “steroid responders”—using corticosteroid eye drops changes how the cells in the trabecular meshwork function [1][2][3]. The steroids trigger the cells to produce excess proteins that build up inside the drainage tissue [4][5][1]. This buildup makes the spongy meshwork stiff and prevents fluid from flowing out easily, leading to a rise in eye pressure [1][6][7].
Uveitic Glaucoma
Unlike steroid-induced pressure spikes, uveitic glaucoma is caused directly by the inflammation in your eye [6][7][8]. When you have an active flare-up of anterior uveitis, your eye fills with white blood cells, inflammatory proteins, and debris. This debris can physically clog the trabecular meshwork, much like a blocked pipe [6][7][8]. Severe or chronic inflammation can also cause scar tissue to form (called synechiae), which can permanently block fluid from reaching the drain [6][7][8].
How Your Doctor Protects Your Vision
It can be stressful to learn that the medicine treating your inflammation could also cause eye pressure issues. However, your eye doctor is well aware of this risk and actively monitors for it.
- Regular Pressure Checks: Your doctor will check your eye pressure (intraocular pressure, or IOP) at every visit [9][10][11]. They use specialized imaging and tools to look at your eye’s drainage angle to figure out if a pressure spike is from steroids or inflammation [8][7]. Because pressure spikes are often “silent,” these tests are the only reliable way to detect them.
- Pressure-Lowering Drops: If your pressure begins to rise, your doctor can prescribe daily eye drops specifically designed to lower eye pressure and protect your optic nerve [11][12][13].
- Medication Adjustments: If you are a steroid responder, your doctor might switch you to a “softer” steroid drop (such as fluorometholone or loteprednol) that is less likely to raise pressure [14][15][16]. For long-term management, they may also discuss steroid-sparing medications—like oral pills or injections—to control your uveitis without relying heavily on steroids [17][18][19].
By catching pressure spikes early and managing them with drops or medication changes, your doctor can effectively prevent the high pressure from progressing to glaucoma [7][11][12].
Common questions in this guide
Can steroid eye drops cause high eye pressure?
How does anterior uveitis cause glaucoma?
Should I stop my steroid drops if I am worried about high eye pressure?
How will I know if my eye pressure is too high?
What happens if I am a steroid responder and my eye pressure goes up?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current eye pressure, and what number would you consider too high for my eyes?
- 2.Based on my history, do you consider me a 'steroid responder'?
- 3.If my pressure starts to go up, what is our action plan for bringing it back down?
- 4.Are we currently using the lowest effective dose of steroid drops to control my inflammation?
- 5.At what point would we consider switching to a 'softer' steroid drop or exploring steroid-sparing medications?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork.
Kasetti RB, Maddineni P, Millar JC, et al.
Scientific reports 2017; (7(1)):14951 doi:10.1038/s41598-017-14938-0.
PMID: 29097767 - 2
Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W, Wang W, Wu S, et al.
Current eye research 2020; (45(2)):190-198 doi:10.1080/02713683.2019.1657462.
PMID: 31425668 - 3
The Molecular Processes in the Trabecular Meshwork After Exposure to Corticosteroids and in Corticosteroid-Induced Ocular Hypertension.
Liesenborghs I, Eijssen LMT, Kutmon M, et al.
Investigative ophthalmology & visual science 2020; (61(4)):24 doi:10.1167/iovs.61.4.24.
PMID: 32305042 - 4
Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB, Maddineni P, Patel PD, et al.
The Journal of biological chemistry 2018; (293(25)):9854-9868 doi:10.1074/jbc.RA118.002540.
PMID: 29743238 - 5
Rapamycin protects glucocorticoid-induced glaucoma model mice against trabecular meshwork fibrosis by suppressing mTORC1/2 signaling.
Song Y, Wang F, Luo H, et al.
European journal of pharmacology 2025; (990()):177269 doi:10.1016/j.ejphar.2025.177269.
PMID: 39805488 - 6
Characteristics of ocular hypertension and uveitic glaucoma among patients with noninfectious uveitis.
Felfeli T, Rhee J, Eshtiaghi A, et al.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(6)):430-438 doi:10.1016/j.jcjo.2024.02.003.
PMID: 38431271 - 7
High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis.
Ma T, Sims JL, Bennett S, et al.
The British journal of ophthalmology 2022; (106(11)):1520-1523 doi:10.1136/bjophthalmol-2021-318809.
PMID: 34020941 - 8
Uveitic Glaucoma Interest Group Recommendations for Uveitis-Related Ocular Hypertension and Glaucoma Management.
Pantcheva MB, Gangaputra S, Sieck E, et al.
Ocular immunology and inflammation 2025; (33(9)):2153-2167 doi:10.1080/09273948.2025.2542286.
PMID: 40971800 - 9
Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty.
Champagne S, Anctil JL, Goyette A, et al.
Journal francais d'ophtalmologie 2015; (38(7)):588-94.
PMID: 26025033 - 10
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.
Kothari S, Foster CS, Pistilli M, et al.
Ophthalmology 2015; (122(10)):1987-2001.
PMID: 26233626 - 11
Review for Disease of the Year: Treatment of Viral Anterior Uveitis: A Perspective.
Zandi S, Bodaghi B, Garweg JG
Ocular immunology and inflammation 2018; (26(7)):1135-1142 doi:10.1080/09273948.2018.1498109.
PMID: 30096015 - 12
Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma.
Ye Z, Yang Y, Ke W, et al.
Frontiers in public health 2023; (11()):1117412 doi:10.3389/fpubh.2023.1117412.
PMID: 36935679 - 13
Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.
Kusuhara S, Katsuyama A, Matsumiya W, Nakamura M
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2018; (256(4)):809-814 doi:10.1007/s00417-018-3933-9.
PMID: 29468405 - 14
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.
Daniel E, Pistilli M, Kothari S, et al.
Ophthalmology 2017; (124(8)):1196-1208 doi:10.1016/j.ophtha.2017.03.041.
PMID: 28433444 - 15
Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group.
Sen P, Jain S, Mohan A, et al.
Indian journal of ophthalmology 2019; (67(10)):1650-1655 doi:10.4103/ijo.IJO_2143_18.
PMID: 31546501 - 16
Long-term Results of Intraocular Pressure Elevation and Post-DMEK Glaucoma After Descemet Membrane Endothelial Keratoplasty.
Maier AB, Pilger D, Gundlach E, et al.
Cornea 2021; (40(1)):26-32 doi:10.1097/ICO.0000000000002363.
PMID: 32558736 - 17
Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.
Knickelbein JE, Kim M, Argon E, et al.
Expert review of ophthalmology 2017; (12(4)):313-319 doi:10.1080/17469899.2017.1319762.
PMID: 30867672 - 18
The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt-Koyanagi-Harada Disease.
Shinagawa M, Namba K, Mizuuchi K, et al.
Ocular immunology and inflammation 2023; (31(3)):501-505 doi:10.1080/09273948.2022.2037657.
PMID: 35212595 - 19
Multifocal chorioretinitis with progressive subretinal fibrosis in a young child.
Steeples LR, Ashworth J, Jones N
BMJ case reports 2015; (2015()).
PMID: 26468224
This page explains the differences between steroid-induced and uveitic glaucoma for educational purposes only. Always consult your ophthalmologist before changing or stopping your prescribed eye drops.
Get notified when new evidence is published on Anterior uveitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.